James Edward Doyle, Director at EXACT SCIENCES CORP (EXAS), sold 2,000 shares at $57.50 ($115K) on 2024-03-01, disclosed to the SEC on 2024-03-04.
Scheduled sale ($115k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EXAS | SELL | 2023-07-28 | $195K | — | Filing → |
| EXAS | SELL | 2023-06-12 | $254K | — | Filing → |
| EXAS | SELL | 2023-05-31 | $161K | — | Filing → |